DETROIT, May 5, 2025 — In a landscape where less than 1% of venture capital goes to Black founders, Emmanuel Brown has led a $1.2 million raise to expand ChurchSpace, the mission-driven tech company. While Brown spearheaded the funding round, it’s Edwards’ deeply personal story—and unwavering vision—that continues to drive the soul of the company.
Day Edwards Antwi, Founder and President, ChurchSpace Inc.
Emmanuel Brown, Co-Founder and CEO, ChurchSpace Inc.
ChurchSpace helps churches transform underused buildings into income-generating hubs for events, outreach, and even last-mile delivery. With support from the City of Detroit, Mayor Mike Duggan, and investors like Black Ops Ventures, Minor Capital, and Michigan Rise, ChurchSpace is relocating its headquarters from Houston to Detroit to launch a citywide partnership and unlock the economic potential of sacred space.
“I watched my mom struggle just to serve,” said Day Edwards, CEO of ChurchSpace. “She built a church from the ground up, but the financial and emotional strain nearly broke our family. She prayed through overdue bills, stress, and sleepless nights—until she passed from a heart attack and stroke, still trying to keep the ministry going.”
In Texas, churches on the platform have earned up to $100,000 annually, reinvesting income into youth programs, food banks, and community outreach.
“When God gives vision, He makes provision,” Edwards continued. “This isn’t just tech—it’s about godly stewardship, economic justice, and making sure churches can serve and survive.”
“This raise is more than a business milestone—it’s a testament to what happens when strategy meets faith, when the odds are defied and purpose outweighs circumstance,” said Co-CEO Emmanuel Brown.
ChurchSpace is currently onboarding Detroit churches and preparing for a citywide partnership backed by the City of Detroit.
About ChurchSpace ChurchSpace is a tech startup building smart logistics and shared-space solutions by activating underutilized church properties for business, ministry, and community impact.
ROSEVILLE, Calif., May 5, 2025 — RightRev, a leader in automated revenue management, today announced the close of a $13 million Series A funding round, bringing total funding to over $31 million. The investment was co-led by Cheyenne Ventures and Innovius Capital, with notable participation from several repeat investors, including Norwest Venture Partners, Salesforce Ventures and Snowflake Ventures.
Jagan Reddy, RightRev founder and CEO
This investment follows RightRev’s recent recognition as a leader in the 2024 MGI Research Automated Revenue Management Buyers’ Guide. This showcases the company’s position as a trusted solution for enterprise organizations, such as Snowflake, the AI Data Cloud company, and Drata, which rely on RightRev to manage complex revenue scenarios across diverse industries.
The new capital will accelerate RightRev’s product innovation, go-to-market expansion and partner ecosystem growth as the company scales to meet the surging demand for revenue automation, especially in the AI era.
“Revenue management is no longer a back-office function—it’s a strategic capability,” said Jagan Reddy, CEO and founder of RightRev. “AI is enabling entirely new business models, from on-demand, consumption-based and outcome-driven, that create massive complexity in how companies recognize revenue. RightRev was purpose-built to handle this shift. With this funding and the backing of world-class investors, we’re doubling down on our mission to deliver speed, accuracy and intelligence to revenue teams around the world.”
Backed by Leading Investors “As finance operations modernize, the demand for intelligent automation in revenue systems is accelerating,” said Justin Moore, CEO and founding partner at Innovius Capital. “RightRev transforms revenue recognition from a compliance burden into a source of insight and competitive advantage. With strong enterprise adoption, seamless integrations and a category-defining product, RightRev is poised to become the core system of record for revenue in the AI-powered enterprise.”
“Revenue recognition remains one of the most complex and mission-critical challenges in the back office. With unmatched domain expertise and a platform built to support high-volume, AI-driven business models, Jagan and the RightRev team have redefined the standard,” said Scott Beechuk, partner at Norwest. “We believe RightRev is uniquely positioned to shape the future of revenue automation.”
Setting the Bar for Revenue Management Excellence RightRev’s platform combines deep expertise in revenue accounting with modern software architecture, enabling organizations to manage intricate revenue scenarios while ensuring compliance with ASC 606 and IFRS 15. In addition to its native integration with Salesforce Revenue Cloud, the platform seamlessly connects to upstream and downstream systems across the entire Order-to-Cash lifecycle. This flexibility enables finance teams to operate within their existing environments while benefiting from RightRev’s agility, high-volume processing capabilities and accuracy.
Fueling Innovation and Growth The new funding will support:
Expanding AI capabilities – Embedding AI across the platform to accelerate configuration, automate error detection and streamline high-volume data processing. RightRev’s AI engine powers real-time policy application, anomaly detection and faster implementations, reducing manual effort while increasing audit confidence.
Supporting evolving business models – As companies shift toward on-demand, consumption-based and outcome-driven pricing, revenue recognition becomes exponentially more complex. RightRev is uniquely positioned to address this shift, automating compliance with ASC 606 and IFRS 15 while providing deep insight into current and future revenue performance.
Accelerating market expansion – Scaling sales, marketing, partnerships and customer success to support growing enterprise demand. RightRev’s native integration with Salesforce Revenue Cloud and expanding support for other Order-to-Cash platforms and ERPs make it the ideal choice for finance teams navigating the shift to intelligent revenue infrastructure.
About RightRev RightRev is a comprehensive platform to automate revenue management. The solution helps businesses streamline, recognize, report, analyze and comply with revenue standards. With a focus on speed, accuracy, and efficiency, the company continues to enhance its platform with artificial intelligence (AI) and new capabilities that simplify data migration, implementation and third-party integrations. Trusted by large enterprises and growth-stage companies across many industries, RightRev empowers finance teams to manage complex revenue scenarios and drive strategic growth. Founded in 2020, RightRev has raised more than $31 million from investors that include Norwest Venture Partners, Salesforce Ventures, Snowflake Ventures, Innovius Capital and Cheyenne Ventures.
Deerfield’s Healthcare Innovations Fund III will invest in promising therapeutics, improvements to healthcare delivery, and paradigm-shifting technologies
NEW YORK, May 5, 2025 — Deerfield Management Company, L.P., today announced the closing of the Deerfield Healthcare Innovations Fund III, a fund of over $600 million that aims to advance healthcare by investing in promising therapeutics, improving care delivery models, and elevating emerging technologies with the potential to shift existing paradigms, including machine learning and artificial intelligence.
“There has never been a better time to invest in new and evolving technologies and products across the life science, medical technology, and healthcare service landscape. Advancing knowledge, data, and software capabilities are transforming what is possible to achieve in improving health outcomes,” said James Flynn, Managing Partner at Deerfield.
Enabled by Deerfield’s collaborations with 29 leading research institutions and nine industry partners, Deerfield operationalizes innovation through its in-house ecosystem. Specialized teams like Deerfield Discovery and Development (3DC) and Deerfield Intelligence employ seasoned drug hunters, medical technology innovators, and software developers to identify and advance promising products, services, and technologies, often in partnership with Deerfield-founded entities like Deerfield Catalyst and Genscience.
Deerfield is housed at Cure, a twelve-story healthcare innovation campus located in New York City with a mission to accelerate cures by helping health innovators develop products and services from concept to commercialization. Cure’s resources include state-of-the-art research laboratories and convening spaces and is staffed to support health innovators’ business needs.
Deerfield recognizes that advancing healthcare requires more than a for-profit investment model can provide. In keeping with the firm’s long-standing practice, Healthcare Innovations Fund III will donate a portion of profits not allocated to the fund’s limited partners to the Deerfield Foundation, a not-for-profit organization focused on improving the health of children worldwide. Since its inception in 2005, the Deerfield Foundation has partnered with a diverse slate of healthcare-focused non-profits to make a difference in the lives of patients and families, from clinics in the South Bronx to care facilities in the highlands of Nepal. Foundation funds are provided via employee contributions as well as fund profits.
Deerfield has invested in and supported the healthcare industry for over 30 years. Today the firm employs more than 180 professionals, with specialized knowledge that spans clinical and translational medicine, drug and medical device development, healthcare policy and markets, machine learning and data science, biostatistics, value-based care, financial instruments, operations, corporate strategy, market access research, sector dynamics, and more, which can be leveraged by corporate and strategic partners.
About Deerfield Management
Deerfield is an investment management firm committed to advancing healthcare through investment, information, and philanthropy. The Firm works across the healthcare ecosystem to connect people, capital, ideas, and technology in bold, collaborative, and inclusive ways. For more information, please visit www.deerfield.com.
Contact Jessica Sagers, PhD, Head of Communications [email protected]
DETROIT, May 5, 2025 — In a bold move blending faith, innovation, and economic revitalization, ChurchSpace has announced the close of a $1.2 million oversubscribed funding round, led by Black Ops Ventures, with additional participation from Dug Song of Minor Capital and Michigan Rise.
The startup is also relocating its national headquarters from Houston, Texas, to Detroit, Michigan — a city known for its rich spiritual legacy and entrepreneurial spirit — to deepen its mission of activating underutilized sacred spaces for modern-day community use.
Day Edwards Antwi, Founder and President, ChurchSpace Inc.
Emmanuel Brown, Co-Founder and CEO, ChurchSpace Inc.
As part of its national growth, ChurchSpace has also launched a historic partnership with the City of Detroit. This groundbreaking initiative will activate church campuses across Detroit not only as flexible event spaces and business hubs but also as micro-logistics and last-mile delivery centers — positioning churches as powerful engines of economic development, job creation, and community support.
“This raise is more than a business milestone—it’s a testament to what happens when strategy meets faith. In today’s climate, raising capital takes grit and resilience—especially without deep networks or traditional access. By God’s grace, doors have opened, and our mission is clearer than ever. Now, with capital in hand, we’re building boldly toward a future where the Church isn’t just surviving—but leading community transformation. We’re deeply grateful to our investors, supporters, champions, and our incredible team,” said Emmanuel Brown, Co-CEO of ChurchSpace.
“What we built in Houston was more than technology—it was transformation. We expanded our purpose and packaged proven strategies to help churches thrive, transform communities, and even combat food insecurity. Now, with prayer and the support of our team and investors, we’re bringing that same impact to Detroit—to help churches, communities, and small businesses redefine pulpits and rediscover communal possibilities,” said Day Edwards, Founder of ChurchSpace.
Through this new model, ChurchSpace is equipping churches to host local businesses, pop-up markets, and community events while also serving as fulfillment hubs for food distribution, retail partnerships, and last-mile delivery services. By using existing, often underutilized real estate inside church campuses — such as fellowship halls, kitchens, and classrooms — ChurchSpace unlocks new streams of passive income for churches while helping small businesses reach local consumers faster and more affordably.
Already, churches on the ChurchSpace platform in Texas have generated up to $100,000 annually in new revenue—funds that have been reinvested into ministries, food programs, and community initiatives. In Detroit, ChurchSpace projects hundreds of direct and indirect jobs will be created in logistics support, delivery management, event hosting, and technical services.
Mayor Mike Duggan praised the partnership, noting the longstanding role churches have played in Detroit’s community fabric.
“We welcome ChurchSpace’s investment in Detroit and the jobs and innovation it will bring. Our faith community has long been a critical backbone of our neighborhoods. Through ChurchSpace’s groundbreaking work, they will continue to be anchors of opportunity and resilience in our city’s future,” said Mayor Mike Duggan.
Investors also praised the vision behind ChurchSpace’s mission:
“From Motown to ministry, Detroit’s always had soul. ChurchSpace is bringing fresh tech to sacred spaces—helping churches thrive, serve, and connect across communities. We’re proud to support their mission and welcome them to Detroit,” said Dug Song, of Minor Capital.
“ChurchSpace is leveraging technology and network effects to transform underutilized space into a powerful resource for communities. We’re thrilled to support their growth, especially as they start making an impact in Michigan,” said Pete Martin, Director of Portfolio Management at Michigan Rise.
“This investment is about more than scaling a platform—it’s about scaling hope, resilience, and opportunity at the neighborhood level. ChurchSpace is exactly the kind of visionary innovation Black Ops Ventures is proud to back,” said Antonia Dean, Principal at Black Ops Ventures.
Churches across Detroit are invited to apply to participate in the pilot program. Selected churches will be onboarded, equipped with new tools for space sharing, revenue generation, and logistics support, and will play a key role in building Detroit’s next chapter of faith-powered economic growth.
To kick off the launch, ChurchSpace will host its Detroit Pastor Meetup on July 19, 2025 — an invitation-only lunch and learn event for pastors and church administrators to learn about ChurchSpace’s model, share their needs, and begin building customized community solutions.
About ChurchSpace ChurchSpace is a tech startup building smart solutions for shared space and logistics through underutilized community infrastructure, helping churches transform their available real estate into purpose-filled spaces for businesses and the community.
Atlas Data Storage is an information technology company building data storage products leveraging the unique properties of synthetic DNA
Data storage and DNA technology veterans Varun Mehta, George Kadifa, and Bill Banyai to lead company
The company recently raised initial seed financing and completed the acquisition of DNA data storage assets from Twist Bioscience
SOUTH SAN FRANCISCO, Calif., May 5, 2025 — Atlas Data Storage, Inc., a technology company building end-to-end DNA data storage, announced today the close of a $155 million seed financing and the acquisition of technology assets from Twist Bioscience.
Atlas is focused on commercializing data storage products that leverage the unique properties of synthetic DNA: extremely high data density, 1,000+ year durability, unlimited low-cost copies, and scalability. The company is spearheading the convergence of synthetic biology and information technology. Atlas’ core technology combines novel semiconductor chips and enzyme engineering, ushering in a new era of high-throughput and massively parallel chemistry performed on a chip.
Atlas data center products will equip hyperscaler, enterprise, and government customers to meet the data storage demands of the AI era with low cost, ultra-high density, secure, scalable storage. DNA data storage will be designed to enable greener data centers with permanent storage that requires no ongoing migration or rewriting, reduced power demands, and minimized carbon impact and e-waste.
The company is led by an integrated team of data storage industry veterans and DNA and semiconductor technology experts. Varun Mehta, highly experienced in the data storage industry, will serve as CEO. Mehta is a veteran of several successful startups and was a founder of Nimble Storage, which was acquired by Hewlett Packard in 2017. Bill Banyai, who previously developed DNA sequencing technology at Complete Genomics and DNA synthesis technology at Twist Bioscience, will serve as CTO. George Kadifa, a tech industry veteran who served in key positions at Hewlett Packard, IBM, Oracle, and Silver Lake, will assume the role of Executive Chairman.
“The opportunity to create an entirely new storage medium does not arise often. At Atlas Data Storage, we are pioneering the use of DNA for high-capacity storage,” said Varun Mehta, CEO of Atlas. “DNA enables highly scalable, ultra-dense, secure, permanent data storage, and the potential to reshape storage is tremendous. Atlas has the right team and technology to realize this promise.”
“Data is central to the modern economy, and the amount of stored data is growing rapidly,” said George Kadifa, Executive Chairman of Atlas. “New technologies such as artificial intelligence are further accelerating demand for storage. I’m confident that the data storage technology that Atlas is creating will enable storing billions and billions of terabytes at low cost, power, and waste. Atlas is also driving US leadership in key technology domains, which will have an immense long-term economic and national security impact.”
The seed financing investors are ARCH Venture Partners, Deerfield Management, Bezos Expeditions, Tao Capital Partners, Rsquared VC, Earth Foundry, In-Q-Tel (IQT), and other undisclosed investors.
About Atlas Data Storage, Inc. Atlas Data Storage is a technology company building end-to-end DNA data storage. For additional information, please visit www.AtlasDS.com.
MIAMI and FRANKLIN, Tenn., May 5, 2025 — Thoma Bravo, a leading software investment firm, today announced a strategic growth investment of more than $100 million in HubSync, the premier all-in-one tax and accounting platform, automating CPA firms. The investment is expected to accelerate HubSync’s product roadmap and customer service, as well as enable continued growth and innovation.
HubSync is a leader in tax and accounting automation and client experience, empowering accounting firms and tax professionals with its innovative platform that drives efficiency, accuracy, and enhanced workflows for its clients. More than 85% of top CPA firms rely on five or more software point solutions to manage their workflows—which allow all-in-one modern and automated solutions like HubSync to drive significant ROI in comparison.
Founded in 2019, HubSync has experienced rapid growth, achieving 744% revenue expansion from 2020 to 2024 while delivering strong profitability. Today, HubSync serves some of the largest CPA firms in the U.S. who have transformed their client facing experience and internal accounting preparation workflow with HubSync’s innovative solutions. HubSync has over 40% of the top 25 accounting firms in the United States as customers, with a robust pipeline of future growth.
“HubSync’s mission to modernize tax and accounting technology has reshaped the industry,” said John McGowan, Founder and CEO of HubSync. “Thoma Bravo’s expertise in scaling software companies will help accelerate our innovation, expand our industry reach, and enhance the value we deliver to our clients.”
Prior to founding HubSync, John spent more than 20 years driving technology and innovation as KPMG’s Chief Information Officer for global tax and and leading Tax Technology at Deloitte.
“This investment is a testament to the strength of our platform and team. We look forward to partnering with Thoma Bravo to drive further growth and transformation of the tax and accounting landscape,” says John McGowan.
“HubSync’s cutting-edge technology and market leadership position it as a standout in the tax and accounting software space,” said Ross Devor, a Partner at Thoma Bravo. “John and his team have used their deep industry experience to build a platform that meets the critical needs of tax and accounting professionals as they seek to unlock efficiencies and streamline their workflows, as well as elevate customer experience and satisfaction. We see tremendous potential to scale HubSync’s solutions and capture a larger share of this growing market.”
“We’ve been impressed by HubSync’s rapid growth and innovative approach,” said Dillon Biddiscombe, a Vice President at Thoma Bravo. “We’re excited to leverage our operational expertise to support HubSync’s next phase of expansion.”
Kaizen Equity Partners served as financial advisor and Taft Law acted as legal counsel to HubSync. Goodwin served as legal counsel to Thoma Bravo.
About HubSync
HubSync is a leading provider of tax compliance and workflow automation software currently servicing the leading CPA firms across the US and Canada, representing over 100% customer growth over the last year. Headquartered in Franklin, Tennessee, HubSync was founded in 2019 and has been recognized on the 2024 Deloitte Technology Fast 500 for its 550% revenue growth. For more information, visit www.hubsync.com.
About Thoma Bravo Thoma Bravo is one of the largest software-focused investors in the world, with over US$179 billion in assets under management as of December 31, 2024. Through its private equity, growth equity and credit strategies, the firm invests in growth-oriented, innovative companies operating in the software and technology sectors. Leveraging Thoma Bravo’s deep sector knowledge and strategic and operational expertise, the firm collaborates with its portfolio companies to implement operating best practices and drive growth initiatives. Over the past 20+ years, the firm has acquired or invested in approximately 520 companies representing approximately US$275 billion in enterprise value (including control and non-control investments). The firm has offices in Chicago, Dallas, London, Miami, New York and San Francisco. For more information, visit Thoma Bravo’s website at thomabravo.com.
Investment positions SETWorks for accelerated innovation and expanded impact in disability services
KANSAS CITY, Mo., May 2, 2025 — SETWorks, a leading software provider for disability service agencies and human services providers, has secured a strategic growth investment from Polaris Growth Fund (PGF).
Founded in the early 2000s, SETWorks delivers industry-leading software and services, tailored specifically to the disability services sector, empowering organizations to spend more time on impacting the lives of the individuals they serve.
The company’s purpose-built platform enables administrators and direct support professionals to efficiently manage complex state-specific compliance and funding requirements, significantly improving productivity, billing reimbursements, and access to quality data at their fingertips, ultimately facilitating increases in community reach and impact.
“The motivation for seeking an investment partner was to further fulfill SETWorks’ mission of empowering those who serve others,” said Henri McCracken, co-chief executive officer of SETWorks. “We were extremely selective in finding a partner who shares our vision, and we are ecstatic to have found PGF, and humbled by their conviction in us. This partnership will enable us to continue innovating and supporting providers on a larger scale across the entire spectrum of disability services.”
Co-Chief Executive Officer David Lindell added “I’m thrilled about how this partnership will enable us to enhance the support and services we provide to the incredible organizations we serve. We care deeply about the vital work they do and the lives they impact, and this investment will help us serve them even better. It will directly accelerate product improvements, including the expansion of our AI capabilities, making a tangible difference for our clients and the individuals they support.”
McCracken and Lindell will continue to lead SETWorks and serve on its board of directors.
“SETWorks has transformed the IDD landscape by combining deep industry expertise with innovation to deliver valuable technology to resource-constrained agencies nationwide,” said Bryce Youngren, managing partner at PGF who will join the SETWorks board of directors. “Together with David and Henri, we are grateful for the opportunity to support SETWorks’ vision for the next chapter of growth.”
“This investment exemplifies the kind of passionate team we seek to partner with,” said Jeff Del Presto, vice president at PGF, who will also join the board. “We believe SETWorks is poised for category leadership and industry-wide impact, and we’re excited to accelerate its mission.”
About SETWorks
SETWorks is a leading technology provider dedicated to empowering disability service agencies and human services providers. With over 20 years of expertise, SETWorks serves organizations in 38 states, enabling them to streamline operations, enhance compliance, and deliver impactful services.
In her new role, Khubani will spearhead enhancing portfolio monitoring, optimizing investment decisions, and strengthening risk management strategies.
MENLO PARK, Calif., May 2, 2025 — Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to venture and non-venture-backed companies, today announced the promotion of Avisha Khubani to Managing Director of Portfolio Analytics. In her expanded role, Khubani will continue to oversee the performance of Runway’s portfolio companies while enhancing Runway’s risk assessment and monitoring frameworks to ensure sustainable growth for its investments.
Khubani, who joined Runway in 2018 as a Vice President, has played a key role in shaping the firm’s portfolio analytics function.
Prior to joining Runway, Khubani was a Vice President in the Portfolio Valuation service line at Kroll Inc. (f/k/a Duff & Phelps), where she specialized in valuing complex portfolios of private loans and equity, including senior secured and subordinated debt, convertible preferred and common equity, and other structured financial instruments. She also gained significant expertise in business and intangible asset valuation as an associate at Empire Valuation Consultants and has held finance roles within multiple venture-backed companies.
“Avisha has been a key contributor to Runway’s success, bringing deep analytical rigor and a strong understanding of risk management to our investment platform,” said David Spreng, Founder and CEO of Runway. “Her leadership and expertise have been invaluable in optimizing our portfolio’s performance, and we are thrilled to recognize her contributions with this well-deserved promotion.”
“It’s been an incredible journey at Runway, and I am excited to step into this expanded role,” said Khubani. “Runway’s commitment to providing strategic growth capital to innovative companies aligns with my commitment to disciplined investing and thoughtful portfolio management. I look forward to continuing to support our borrowers and investors with industry-leading insights and risk frameworks.”
Khubani holds an M.B.A. from the New York University Stern School of Business and an undergraduate degree from Montclair State University. She is also a Chartered Financial Analyst (CFA).
About Runway Growth Capital LLC Runway Growth Capital LLC is the investment adviser to investment funds, including Runway Growth Finance Corp. (Nasdaq: RWAY), a business development company, and other private funds, which are lenders of growth capital to companies seeking an alternative to raising equity. Led by industry veteran David Spreng, these funds provide senior term loans of a target of $10 million to $150 million to fast-growing companies based in the United States and Canada. For more information on Runway Growth Capital LLC and its platform, please visit www.runwaygrowth.com.
Forward-Looking Statements Statements included herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition, or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in filings with the Securities and Exchange Commission made by Runway and Runway’s affiliated funds. Neither Runway nor Runway’s affiliated funds undertake a duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
SINGAPORE, May 1, 2025 — HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic diseases, has announced the close of a S$9 million investment round to support its next phase of expansion. OCBC, the longest established bank in Singapore and the second largest financial services group in Southeast Asia by assets, investing for the first time in a medical technology/healthcare company, leads the round with continued support from two existing shareholders – ZIG Ventures and SEEDS Capital, an investment arm of SG Growth Capital.
Daniel Kwan, Global Head of the Mezzanine Capital Unit at OCBC, said: “HistoIndex’s groundbreaking technology has revolutionized liver disease diagnostics through cutting-edge AI innovations, and has the potential to enhance global healthcare by enabling precise and personalized patient care. We are proud to support this homegrown MedTech company with its growth plans and international ambitions.”
With the increasing demand for routine clinical testing of Metabolic Dysfunction-Associated Steatohepatitis (MASH), particularly in liver biopsy assessment, this investment is focused on 1) expanding HistoIndex-partnered laboratories and operations within the US; and 2) developing next-generation AI-powered SHG digital pathology tests for MASH patients.
In line with this mission, HistoIndex has recently launched its very first Laboratory Developed Test (LDT), FibroSIGHT™ – now available for order in the US. FibroSIGHT™ is designed to empower clinicians with accurate and consistent liver fibrosis assessment1. The first in a pipeline of new product launches reaffirms HistoIndex’s commitment to revolutionizing personalized treatment for MASH. By integrating research in pivotal clinical trials with clinical practice, the company is advancing precision medicine with the aim of improving patient outcomes worldwide.
“This investment plays an enabling role in positioning the company for strategic expansion within the US, while accelerating the adoption of advanced digital pathology solutions poised to transform MASH diagnosis and treatments.” said Dr. Gideon Ho, Chief Executive Officer of HistoIndex.
About MASH
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive form of Metabolic dysfunction-associated steatotic liver disease (MASLD) characterized by steatosis and inflammation, which can lead to fibrosis (scarring), cirrhosis, liver failure, and an increased risk of liver cancer. The presence of ballooned hepatocytes (enlarged and damaged liver cells) is a key feature distinguishing MASH from simple steatosis. Pathologist assessments of liver biopsy remain the gold standard for diagnosing and assessing the severity of MASH. Histological categorial scoring systems are often used as surrogate endpoints to evaluate drug efficacy in clinical trials. These endpoints are limited in capturing the complex and heterogeneous nature of the disease. As a result, there is a growing need for more accurate and reliable tools, such as AI-based digital pathology solutions, to improve the assessment of treatment response and disease severity in MASH.
About HistoIndex
Founded in 2010, HistoIndex pioneers in stain-free, fully automated imaging solutions for visualizing and quantifying fibrosis in biological tissues. By combining cutting-edge biophotonic technology with AI-based analysis, HistoIndex provides innovative tools to improve the assessment of fibrosis changes and drug efficacy. HistoIndex’s breakthrough digital pathology solutions are currently used in accelerating clinical research, expediting pharmaceutical drug development, and transforming medical standards.
